These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8041257)
21. A new type of artificial oxygen carrier: soluble hyperpolymeric haemoglobin with negligible oncotic pressure--production of thermally stable hyperpolymers from human blood with glutaraldehyde as cross-linker. Pötzschke H; Barnikol WK Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):287-91. PubMed ID: 1391444 [No Abstract] [Full Text] [Related]
23. Studies on haemoglobin immobilized by cross-linking with glutaraldehyde. Cross-linked soluble polymers and artificial membranes. Guillochon D; Esclade L; Remy MH; Thomas D Biochim Biophys Acta; 1981 Oct; 670(3):332-40. PubMed ID: 6794642 [TBL] [Abstract][Full Text] [Related]
24. Preparation of conjugated hemoglobins. Xue H; Wong JT Methods Enzymol; 1994; 231():308-22. PubMed ID: 7518888 [No Abstract] [Full Text] [Related]
25. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin. D'Agnillo F; Alayash AI Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790 [TBL] [Abstract][Full Text] [Related]
27. Oxidized mono-, di-, tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes. Eike JH; Palmer AF Biotechnol Prog; 2004; 20(3):953-62. PubMed ID: 15176904 [TBL] [Abstract][Full Text] [Related]
28. Stabilities and properties of multilinked hemoglobins. Olsen KW; Zhang QY; Huang H; Sabaliauskas GK; Yang T Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):283-5. PubMed ID: 1391443 [TBL] [Abstract][Full Text] [Related]
29. Quality control of hemoglobin-based blood substitutes. Hsia JC; Er SS Biomater Artif Cells Artif Organs; 1988; 16(1-3):105-11. PubMed ID: 3179461 [TBL] [Abstract][Full Text] [Related]
30. A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization. Prouchayret F; Fasan G; Grandgeorge M; Vigneron C; Menu P; Dellacherie E Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):319-22. PubMed ID: 1382641 [TBL] [Abstract][Full Text] [Related]
31. Bissulfosuccinimidyl esters of aliphatic dicarboxylic acids: a new class of 'affinity directed' beta beta crosslinkers of HbA. Manjula BN; Roy RP; Smith PK; Acharya AS Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):747-52. PubMed ID: 7994397 [TBL] [Abstract][Full Text] [Related]
32. Diaspirin crosslinked hemoglobin (DCLHb): characterization of the process and the product manufactured under GMP requirements for clinical studies. Azari M; Rohn K; Picken J Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):701-8. PubMed ID: 7994391 [TBL] [Abstract][Full Text] [Related]
33. NMR study of the sites of human hemoglobin acetylated by aspirin. Xu AS; Macdonald JM; Labotka RJ; London RE Biochim Biophys Acta; 1999 Jul; 1432(2):333-49. PubMed ID: 10407155 [TBL] [Abstract][Full Text] [Related]